These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38868205)

  • 1. Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines.
    Tlemsani C; Heske CM; Elloumi F; Pongor L; Khandagale P; Varma S; Luna A; Meltzer PS; Khan J; Reinhold WC; Pommier Y
    iScience; 2024 Jun; 27(6):109781. PubMed ID: 38868205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines.
    Rajapakse VN; Luna A; Yamade M; Loman L; Varma S; Sunshine M; Iorio F; Sousa FG; Elloumi F; Aladjem MI; Thomas A; Sander C; Kohn KW; Benes CH; Garnett M; Reinhold WC; Pommier Y
    iScience; 2018 Dec; 10():247-264. PubMed ID: 30553813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.
    Reinhold WC; Varma S; Sunshine M; Elloumi F; Ofori-Atta K; Lee S; Trepel JB; Meltzer PS; Doroshow JH; Pommier Y
    Cancer Res; 2019 Jul; 79(13):3514-3524. PubMed ID: 31113817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples.
    Arakawa Y; Elloumi F; Varma S; Khandagale P; Jo U; Kumar S; Roper N; Reinhold WC; Robey RW; Takebe N; Gottesman MM; Thomas CJ; Boeva V; Berruti A; Abate A; Tamburello M; Sigala S; Hantel C; Weigand I; Wierman ME; Kiseljak-Vassiliades K; Del Rivero J; Pommier Y
    Cancer Res Commun; 2024 Sep; 4(9):2384-2398. PubMed ID: 39162009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations.
    Reinhold WC; Wilson K; Elloumi F; Bradwell KR; Ceribelli M; Varma S; Wang Y; Duveau D; Menon N; Trepel J; Zhang X; Klumpp-Thomas C; Micheal S; Shinn P; Luna A; Thomas C; Pommier Y
    Cancer Res; 2023 Jun; 83(12):1941-1952. PubMed ID: 37140427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.
    Luna A; Elloumi F; Varma S; Wang Y; Rajapakse VN; Aladjem MI; Robert J; Sander C; Pommier Y; Reinhold WC
    Nucleic Acids Res; 2021 Jan; 49(D1):D1083-D1093. PubMed ID: 33196823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines.
    Guo T; Luna A; Rajapakse VN; Koh CC; Wu Z; Liu W; Sun Y; Gao H; Menden MP; Xu C; Calzone L; Martignetti L; Auwerx C; Buljan M; Banaei-Esfahani A; Ori A; Iskar M; Gillet L; Bi R; Zhang J; Zhang H; Yu C; Zhong Q; Varma S; Schmitt U; Qiu P; Zhang Q; Zhu Y; Wild PJ; Garnett MJ; Bork P; Beck M; Liu K; Saez-Rodriguez J; Elloumi F; Reinhold WC; Sander C; Pommier Y; Aebersold R
    iScience; 2019 Nov; 21():664-680. PubMed ID: 31733513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics sciences and precision medicine in sarcoma.
    Bonetti G; Donato K; Dhuli K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Cavalca D; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):68-76. PubMed ID: 37994750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review of the Current Status of Human Sarcoma Cell Lines.
    Hattori E; Oyama R; Kondo T
    Cells; 2019 Feb; 8(2):. PubMed ID: 30781855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of publicly available sarcoma cell lines for use in proteomic studies.
    Pan X; Yoshida A; Kawai A; Kondo T
    Expert Rev Proteomics; 2016; 13(2):227-40. PubMed ID: 26653594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
    Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
    Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma.
    Kerrison WGJ; Ning J; Krasny L; Arthur A; Guljar N; Elms ML; Swain A; Jones RL; Thway K; Huang PH
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
    Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ
    Clin Orthop Relat Res; 2024 Mar; 482(6):1028-37. PubMed ID: 38517415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas.
    Chadha M; Huang PH
    Curr Treat Options Oncol; 2022 Jan; 23(1):78-88. PubMed ID: 35171456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.
    Hingorani P; Janeway K; Crompton BD; Kadoch C; Mackall CL; Khan J; Shern JF; Schiffman J; Mirabello L; Savage SA; Ladanyi M; Meltzer P; Bult CJ; Adamson PC; Lupo PJ; Mody R; DuBois SG; Parsons DW; Khanna C; Lau C; Hawkins DS; Randall RL; Smith M; Sorensen PH; Plon SE; Skapek SX; Lessnick S; Gorlick R; Reed DR
    Cancer Genet; 2016 May; 209(5):182-94. PubMed ID: 27132463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomic studies addressing unmet clinical needs in sarcoma.
    Connolly EA; Grimison PS; Horvath LG; Robinson PJ; Reddel RR
    Front Oncol; 2023; 13():1126736. PubMed ID: 37197427
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.